Conference - Philadelphia, PА, United States
Paradigm Global Events is proud to present Biosimilars and Follow-On Biologics Americas 2014. Biosimilars also known as Follow-on Biologics or subsequent entry biologics are official subsequent version of innovator pharmaceutical products on which reference to the innovator product is crucial component for approval. This conference examines a number of challenges including commercial, regulatory, and technical, all of them in turn and discusses for example: the current commercial trends of biosimilars; what the commercial impact of them is; and what is happening in the BRIC countries. The conference also looks at the latest global regulatory guidelines and issues surrounding biosimilars and what this means for the data exclusivity, is there a need for a balance between innovation and competition? Technical issues with biosimilars however are the major concern. Biological drugs unlike the more common small-molecule drugs maybe more sensitive to changes in manufacturing process due to its high molecular complexity, so biosimilar producers have to prove that the overall effects are the same.
Event Institution: Paradigm Global Events
(Courtesy of Biosimilars, via magazine.merckgroup.com)
10th February 2014 - 12th February 2014 (08:00 - 18:00)
Philadelphia, Pennsylvania, USA
Phone: 0044 (0)20 7193 3485
Contact: Jocelyn Raguindin (firstname.lastname@example.org)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.